| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
ARG1
|
arginase 1
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD209
|
CD209 molecule
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHIA
|
chitinase, acidic
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DEFB1
|
defensin, beta 1
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DHFR
|
dihydrofolate reductase
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EP300
|
E1A binding protein p300
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ESR1
|
estrogen receptor 1
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAS
|
Fas cell surface death receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FMO1
|
flavin containing monooxygenase 1
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXP3
|
forkhead box P3
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
|
GART
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
|
GATA3
|
GATA binding protein 3
|
|
GNLY
|
granulysin
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDC
|
histidine decarboxylase
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HNMT
|
histamine N-methyltransferase
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNA14
|
interferon, alpha 14
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNA5
|
interferon, alpha 5
|
|
IFNA6
|
interferon, alpha 6
|
|
IFNA8
|
interferon, alpha 8
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL18
|
interleukin 18
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL26
|
interleukin 26
|
|
IL27
|
interleukin 27
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF9
|
interferon regulatory factor 9
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LIPC
|
lipase, hepatic
|
|
LPL
|
lipoprotein lipase
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUC7
|
mucin 7, secreted
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PF4
|
platelet factor 4
|
|
PGR
|
progesterone receptor
|
|
PHF11
|
PHD finger protein 11
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGES2
|
prostaglandin E synthase 2
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RPAIN
|
RPA interacting protein
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SELL
|
selectin L
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPA2
|
surfactant protein A2
|
|
SFTPB
|
surfactant protein B
|
|
SFTPC
|
surfactant protein C
|
|
SFTPD
|
surfactant protein D
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TACR3
|
tachykinin receptor 3
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBX1
|
T-box 1
|
|
TBX21
|
T-box 21
|
|
TBX5
|
T-box 5
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TYK2
|
tyrosine kinase 2
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
